Usage: CORTROSYN is indicated as a diagnostic agent, in combination with other tests, for screening adrenocortical insufficiency in both adults and pediatric patients.
Usage: Cosyntropin for injection is indicated as a diagnostic agent, used alongside other tests, to screen for adrenocortical insufficiency in both adults and pediatric patients.
Usage: The drug is indicated for severe allergies, dermatologic and endocrine disorders, gastrointestinal and hematologic diseases, neurogenic conditions, neoplastic diseases, and various conditions across respiratory, ophthalmic, renal, and rheumatic diseases. It serves to manage symptoms or provide palliative care in specific cases.
Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.
Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, collagen diseases, severe allergic states, ophthalmic and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions, as well as for diagnostic testing of adrenocortical hyperfunction.
Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.
Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, allergic states, gastrointestinal diseases, respiratory diseases, hematologic disorders, and certain dermatologic and ophthalmic diseases. It can be administered intravenously, intramuscularly, intra-articular, or intralesionally for acute episodes and management of chronic conditions.
Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.
Usage: This drug is indicated for intravenous or intramuscular use in endocrine disorders, rheumatic disorders, collagen diseases, dermatologic conditions, severe allergic states, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and acute exacerbations of multiple sclerosis, among other conditions.
Usage: Fludrocortisone acetate tablets, 0.1 mg, are indicated for partial replacement therapy in primary and secondary adrenocortical insufficiency (Addison's disease) and for treating salt-losing adrenogenital syndrome.